Investing Ideas
/
Slovenian Healthy potentially undervalued

Slovenian Healthy potentially undervalued

Results

0 new

Companies which are potentially undervalued and in an acceptable financial position.

2 companies

Krka d. d

Market Cap: €7.2b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

KRKG

€237.00

1.7%

45.0%

Nova Ljubljanska Banka d.d

Market Cap: €4.0b

Provides various banking services for retail and corporate clients in Slovenia, South East Europe, and Western Europe.

NLBR

€199.50

8.1%

42.5%